资源类型:
期刊
WOS体系:
Article
Pubmed体系:
Journal Article
收录情况:
◇ SCIE
文章类型:
论著
机构:
[1]School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong,510515, China.
[2]Shenzhen Traditional Chinese Medicine Hospital, Shenzhen,518005, China.
[3]Medical Laboratory of the Third affiliated Hospital of Shenzhen University, Shenzhen, 518001, China.
深圳市罗湖区人民医院
深圳医学信息中心
[4]School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong,510515, China. Electronic address: hshtcm@126.com.
[5]ZhuJiang Hospital of Southern Medical University, Guangzhou, Guangdong, 510285, China. Guangdong Provincial Key Laboratory of Shock and Microcirculation, Southern Medical University, Guangzhou,510515, PR China. Electronic address: raygaolei@smu.edu.cn.
[6]School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong,510515, China. Electronic address: lzp48241@126.com.
ISSN:
2352-345X
摘要:
Acute liver failure (ALF) is a condition with high mortality and morbidity, characterized by GSH depletion, oxidative stress, and mitochondrial dysfunction. Ferroptosis may be involved in ALF. Indeed, emerging studies have demonstrated that ferroptosis plays a significant role in ALF. However, the mechanism of ferroptosis in hepatocytes during ALF remains unknown.Hepatic specific TGFβr1 knockout (TGFβr1Δhep-CKO) mice and nuclear factor erythroid 2-related factor 2 knockout(Nrf2-/-)mice were generated and subjected to ALF. Electron microscopy was used to detect mitochondrial and other cell substructure changes during ALF.In this study, we noticed that LPS/GalN induced caspases-mediated apoptosis as current research reported, we also found lipid peroxidation, ROS accumulation, and glutathione (GSH), coenzyme Q10 (CoQ10) system inhibition mediated ferroptosis during LPS/GalN induced-ALF. Rescue studies showed that ferrostatin-1(Fer-1) and Deferoxamine mesylate (DFMO), the inhibitor of ferroptosis, could alleviate LPS/GalN-induced ALF. Additionally, we noticed that TGFβ1 was increased during ALF, while ALF was relieved in TGFβr1Δhep-CKO mice. We also noticed that liver TGFβr1 deficiency alleviated LPS/GalN-induced apoptosis and ferroptosis by affecting the phosphorylation of glycogen synthase kinase3β (P-GSK3β) and nuclear factor erythroid 2-related factor 2(Nrf2), a key antioxidant factor, by up-regulating the levels of GPX4, XCT, DHODH and FSP1, and down-regulating TFR, Ptgs2, CHAC1, and POR expression. The further supplemental experiment showed that ferroptosis was significantly aggravated in Nrf2-/-mice compared with its WT controls and reversed by Fer-1.This study demonstrates that TGFβr1 plays a critical role in mediating LPS/GalN-induced ALF by promoting apoptosis and ferroptosis.Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
WOS:
WOS:000795803200003
PubmedID:
35202887
中科院(CAS)分区:
出版当年[2021]版:
大类
|
1 区
医学
小类
|
2 区
胃肠肝病学
最新[2025]版:
大类
|
1 区
医学
小类
|
2 区
胃肠肝病学
JCR分区:
出版当年[2020]版:
Q1
GASTROENTEROLOGY & HEPATOLOGY
最新[2023]版:
Q1
GASTROENTEROLOGY & HEPATOLOGY
影响因子:
7.1
最新[2023版]
7.9
最新五年平均
9.225
出版当年[2020版]
8.69
出版当年五年平均
7.076
出版前一年[2019版]
8.797
出版后一年[2021版]
第一作者:
Huang Sha
第一作者机构:
[1]School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong,510515, China.
推荐引用方式(GB/T 7714):
Huang Sha,Wang Yuhua,Xie Shunwen,et al.Hepatic TGFβr1 deficiency attenuates Lipopolysaccharide/D-Galactosamine induced acute liver failure through inhibiting GSK3β-Nrf2-mediated hepatocyte apoptosis and ferroptosis.[J].CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY.2022,13(6):1649-1672.doi:10.1016/j.jcmgh.2022.02.009.
APA:
Huang Sha,Wang Yuhua,Xie Shunwen,Lai Yuqi,Mo Chan...&Lv Zhiping.(2022).Hepatic TGFβr1 deficiency attenuates Lipopolysaccharide/D-Galactosamine induced acute liver failure through inhibiting GSK3β-Nrf2-mediated hepatocyte apoptosis and ferroptosis..CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY,13,(6)
MLA:
Huang Sha,et al."Hepatic TGFβr1 deficiency attenuates Lipopolysaccharide/D-Galactosamine induced acute liver failure through inhibiting GSK3β-Nrf2-mediated hepatocyte apoptosis and ferroptosis.".CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY 13..6(2022):1649-1672